KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeProfit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Eli Lilly (LLY) Consolidated Net Income (2016 - 2025)

Historic Consolidated Net Income for Eli Lilly (LLY) over the last 16 years, with Q3 2025 value amounting to $5.6 billion.

  • Eli Lilly's Consolidated Net Income rose 47533.75% to $5.6 billion in Q3 2025 from the same period last year, while for Sep 2025 it was $18.4 billion, marking a year-over-year increase of 11997.99%. This contributed to the annual value of $10.6 billion for FY2024, which is 10208.38% up from last year.
  • Eli Lilly's Consolidated Net Income amounted to $5.6 billion in Q3 2025, which was up 47533.75% from $5.7 billion recorded in Q2 2025.
  • In the past 5 years, Eli Lilly's Consolidated Net Income registered a high of $5.7 billion during Q2 2025, and its lowest value of -$57.4 million during Q3 2023.
  • Over the past 5 years, Eli Lilly's median Consolidated Net Income value was $1.8 billion (recorded in 2023), while the average stood at $2.2 billion.
  • As far as peak fluctuations go, Eli Lilly's Consolidated Net Income crashed by 10395.4% in 2023, and later skyrocketed by 179041.81% in 2024.
  • Eli Lilly's Consolidated Net Income (Quarter) stood at $1.7 billion in 2021, then increased by 12.26% to $1.9 billion in 2022, then grew by 13.01% to $2.2 billion in 2023, then surged by 101.39% to $4.4 billion in 2024, then rose by 26.59% to $5.6 billion in 2025.
  • Its Consolidated Net Income stands at $5.6 billion for Q3 2025, versus $5.7 billion for Q2 2025 and $2.8 billion for Q1 2025.